Your browser doesn't support javascript.
loading
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche.
Gonzalez-Sanchez, Ester; Vaquero, Javier; Caballero-Diaz, Daniel; Grzelak, Jan; Fusté, Noel P; Bertran, Esther; Amengual, Josep; Garcia-Saez, Juan; Martín-Mur, Beatriz; Gut, Marta; Esteve-Codina, Anna; Alay, Ania; Coulouarn, Cedric; Calero-Perez, Silvia; Valdecantos, Pilar; Valverde, Angela M; Sánchez, Aránzazu; Herrera, Blanca; Fabregat, Isabel.
Afiliación
  • Gonzalez-Sanchez E; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Vaquero J; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Caballero-Diaz D; Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Grzelak J; Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
  • Fusté NP; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Bertran E; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Amengual J; Centro de Investigación del Cancer and Instituto de Biología Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, Salamanca, Spain.
  • Garcia-Saez J; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Martín-Mur B; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Gut M; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Esteve-Codina A; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Alay A; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Coulouarn C; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Calero-Perez S; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Valdecantos P; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Valverde AM; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
  • Sánchez A; Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  • Herrera B; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Fabregat I; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
J Pathol ; 263(4-5): 482-495, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38872438

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetracloruro de Carbono / Transducción de Señal / Hepatocitos / Receptores ErbB Límite: Animals Idioma: En Revista: J Pathol Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetracloruro de Carbono / Transducción de Señal / Hepatocitos / Receptores ErbB Límite: Animals Idioma: En Revista: J Pathol Año: 2024 Tipo del documento: Article País de afiliación: España
...